Moreover, triptolide (40–160 nM for 24 hr) inhibited NF-κB activation by increasing IκBα, an inhibitor of NF-κB, at mRNA and protein levels in multiple myeloma RPMI-8266 cells (Zeng et al., 2011 ▶). The gene discussed is NFKB1; the disease is plasma cell myeloma.